Aayu Medisciences Private Limited
Founded in 2009 and headquartered in Maharashtra, India.
2009 | Nagpur, Maharashtra (India) | Active
Aayu Medisciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 15 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.50 M
About Aayu Medisciences
Aayu Medisciences Private Limited (AMPL) is a Private Limited Indian Non-Government Company incorporated in India on 04 June 2009 and has a history of 15 years and eight months. Its registered office is in Nagpur, Maharashtra, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.50 M.
Sunil Dudhberve and Mina Dudhbarve serve as directors at the Company.
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51109MH2009PTC193019
- Company No.
193019
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Jun 2009
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Trading
Who are the key members and board of directors at Aayu Medisciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sunil Dudhberve  | Director | 17-Dec-2022 | Current |
| Mina Dudhbarve | Director | 17-Dec-2022 | Current |
Financial Performance of Aayu Medisciences.
Aayu Medisciences Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Aayu Medisciences?
In 2017, Aayu Medisciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
Open Charges
₹1.50 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Oriental Bank Of Commerce : 0.15 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Oct 2009 | Oriental Bank Of Commerce | ₹1.50 M | Open |
How Many Employees Work at Aayu Medisciences?
Unlock and access historical data on people associated with Aayu Medisciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aayu Medisciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aayu Medisciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
